Endocrine Today Current Issue
The following articles appeared in the print edition of Endocrine Today.
Table of Contents
- FDA panel recommendation creates mixed opinions about future of rosiglitazone
-
- FDA: Avoid unintentional exposure of children, pets to estrogen spray
- Upcoming study will target optimal treatment of diabetic ketoacidosis
- Treating prediabetes: An overlooked opportunity? Deborah Fillman, MS, RD, LD, CDE
- Barriers to achieving targets, risks of hyperglycemia and hypoglycemia in children Fergus J. Cameron, MD; Timothy W. Jones, MD
- Parathyroidectomy thyroiditis and thyrotoxicosis Stephanie L. Lee, MD, PhD, ECNU; Daniel J. Rubin, MD
- Glucokinase activators offer a potentially promising therapeutic approach for type 2 diabetes Edward C. Chao, DO
- Proposed guidelines would expand osteoporosis screening
- Postmarketing drug safety surveillance: Is enough being done? Rhonda Cooper-DeHoff, PharmD
-
- How do you rank and use medical evidence?